Hinova Pharmaceuticals Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-135.03	-137.25	-199.5	-294.16	-301.51	-306.18
Depreciation & Amortization	7.29	7.29	5.97	6.42	5.47	3.05
Other Amortization	-	-	0.04	0.04	0.04	0.63
Loss (Gain) From Sale of Assets	-	-	0	0.01	0	0
Asset Writedown & Restructuring Costs	-10.17	-10.17	-	-	-	-
Loss (Gain) From Sale of Investments	-5.18	-5.18	-13.11	-24.83	-28.89	-23.56
Other Operating Activities	22.16	0.25	-3.66	-2.78	-3.3	6.05
Change in Accounts Receivable	1.35	1.35	5.92	5.76	4.04	3.96
Change in Inventory	-2.84	-2.84	0	0	-0	-0
Change in Accounts Payable	28.99	28.99	-7.54	-21.85	-93.6	-20.6
Change in Other Net Operating Assets	8.68	8.68	24.79	75.88	102.82	108.82
Operating Cash Flow	-84.75	-108.88	-187.08	-255.51	-314.92	-227.82
Capital Expenditures	-64.46	-82.89	-89.55	-99.18	-69.21	-19.77
Sale of Property, Plant & Equipment	0	0	0	0.02	0	-
Investment in Securities	290	-100	80	-25	-370	-
Other Investing Activities	27.43	43.18	-20.7	24.83	29.31	23.2
Investing Cash Flow	252.97	-139.7	-30.25	-99.33	-409.9	3.42
Short-Term Debt Issued	-	-	-	0.5	30	-
Long-Term Debt Issued	-	100	-	-	-	-
Total Debt Issued	100	100	-	0.5	30	-
Short-Term Debt Repaid	-	-	-	-30.5	-	-0.5
Long-Term Debt Repaid	-	-	-4.06	-4.39	-3.4	-1.56
Total Debt Repaid	-	-	-4.06	-34.89	-3.4	-2.06
Net Debt Issued (Repaid)	100	100	-4.06	-34.39	26.6	-2.06
Issuance of Common Stock	-	-	-	-	1,010	-
Common Dividends Paid	-1.88	-1.24	-	-0.9	-	-2.56
Other Financing Activities	-3.26	-3.52	-	-	-19.31	-3.86
Financing Cash Flow	94.85	95.24	-4.06	-35.29	1,017	-8.48
Foreign Exchange Rate Adjustments	-3.86	-2.29	1.43	1.75	7.8	-1.99
Net Cash Flow	259.21	-155.64	-219.96	-388.38	300.38	-234.87
Free Cash Flow	-149.21	-191.76	-276.63	-354.68	-384.13	-247.6
Free Cash Flow Margin	-320.91%	-936.81%	-75410.46%	-	-23269.07%	-
Free Cash Flow Per Share	-1.51	-1.94	-2.79	-3.58	-4.23	-3.33
Cash Interest Paid	-	-	-	-	3.92	-
Cash Income Tax Paid	1.09	1.12	0.44	-19.4	-13.46	-6.07
Levered Free Cash Flow	-52.28	-311.03	268.67	-230.86	-252.88	-145.13
Unlevered Free Cash Flow	-52.28	-311.03	269	-229.93	-250.43	-143.54
Change in Working Capital	36.19	36.19	23.17	59.79	13.27	92.19

Source: S&P Global Market Intelligence. Standard template. Financial Sources.